HOOKIPA Pharma (HOOK) Net Margin

Graphic logo of HOOKIPA (HOOK)

The lack of stable profit sources and a heavy reliance on R&D create a financial dependency on investments for HOOKIPA Pharma Inc. (HOOK). This chart on GURU.Markets shows that actual net profit margin exhibits volatility, where 0.00 determines the current status of the parameter. This correlates with the development of innovative viral cancer vaccines; however, geopolitical tensions and logistics disruptions are seriously hindering the conduct of global clinical trials.

hookipapharma.com (HOOK) Net Sales Margin: for the period 07/04/2022 - 08/24/2025

Analytical breakdowns for hookipapharma.com (HOOK)

- market value and analyst target forecast:
- market capitalization details:
Initial company analysis:hookipapharma.com, HOOK
Manufactured product of HOOKIPA Pharma Inc.

The development of immunotherapeutic platforms and arenavirus vectors by HOOKIPA Pharma Inc. (HOOK) requires significant expenditures on external contract manufacturing. The company's net margin ratio on GURU.Markets reflects the portion of profit from every dollar of revenue after deducting all expenses. Negative values on this chart signal operational losses for the business. This trend captures the metric's dynamics, allowing investors to timely assess the risk of liquidating a position. Current profitability directly determines the issuer's market capitalization.

Who HOOKIPA Pharma Inc. competes with

argenx (ARGX) - Net Margin|BNTX - Company Sales Margin|ABVX (Abivax Pharma) - Net Sales Margin|Return on Sales by Net Profit ADMA Bio (ADMA)|Return on Sales by Net Profit PTGX (Protagonist Therapeutics Inc)|Net Sales Margin immunovant.com (IMVT)|Net Margin kiniksa.com KNSA|Grifols SA (GRFS) - Net Margin|Adaptive Biotechnologies Inc. - Net Sales Margin|Net Margin Celldex Therapeutics|AUPH: Net Sales Margin|BCRX - Company Sales Margin|VERA (Vera Corp) - Net Sales Margin|Dianthus Pharma (DNTH) - Company Sales Margin|Net Margin Pharvaris Pharma (PHVS)|Net Sales Margin AbCellera Corp (ABCL)|Net Sales Margin TRML (Tourmaline Bio Inc)|Company Sales Margin precigen.com (PGEN)|PHAR - Net Margin|Net Profit Rate NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Return on Sales by Net Profit|Zenas Corp (ZBIO) - Net Sales Margin|Return on Sales by Net Profit IMNM|GOSS: Net Profit Rate|Net Margin KalVista Pharma (KALV)|SEPN - Net Margin|Net Sales Margin PVLA (pieris.com)|Net Sales Margin Savara Pharma SVRA|RIGL: Return on Sales by Net Profit|ANAB - Net Sales Margin|ATXS: Net Sales Margin|ENGN - Company Sales Margin|Return on Sales by Net Profit RAPT|JBIO (Aerovate Therapeutics Inc) - Company Net Profitability|Net Sales Margin ACRS|Return on Sales by Net Profit kyvernatx.com KYTX|Net Sales Margin TLSA (Tiziana Life Sciences, Ltd.)|Net Sales Margin Cabaletta Bio CABA|VTYX: Return on Sales by Net Profit|Theratechnologies Inc. (THTX) - Return on Sales by Net Profit|AVTX: Net Sales Margin|ELDN - Company Sales Margin|AGEN (Agenus, Inc) - Net Sales Margin|Net Sales Margin Climb Bio, Inc.|Net Margin Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Net Profit Rate|Net Sales Margin ADAG (Adagene Inc)|IMA - Return on Sales by Net Profit|STTK - Net Margin|EQ (equilliumbio.com) - Net Return on Sales|CNTB: Net Sales Margin|Immunic Inc (IMUX) - Net Sales Margin|ATRA (Atara Biotherapeutics Inc) - Net Sales Margin|Net Return on Sales IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Net Profit Rate|Adicet Bio, Inc. - Net Return on Sales|Celularity Inc - Return on Sales by Net Profit|Net Sales Margin INmune Bio Corporation INMB|Barinthus Biotherapeutics - Net Sales Margin|Kezar Life Sciences, Inc. (KZR) - Return on Sales by Net Profit|SAB Biotherapeutics Inc. (SABS) - Net Margin|Return on Sales by Net Profit Akari Therapeutics plc|Net Margin enlivex.com|q32bio.com (QTTB) - Company Sales Margin|Net Sales Margin GOVX|Edesa Biotech, Inc. - Net Return on Sales|iBio Inc - Return on Sales by Net Profit|Net Sales Margin Carisma Therapeutics CARM|XTLB - Net Margin|BOLT (boltbio.com) - Net Return on Sales|HCWB: Net Sales Margin|Aptevo (APVO) - Net Sales Margin|Net Margin AIM ImmunoTech|Return on Sales by Net Profit Aditxt (ADTX)|Return on Sales by Net Profit GRI (GRI Bio Corporation)|XORTX - Net Return on Sales|Net Sales Margin HIND (Vyome Holdings Inc.)|Net Profit Rate REVB|Indaptus - Net Sales Margin|SCNI (Scinai Immunotherapeutics Ltd.) - Net Return on Sales|CALI: Net Sales Margin|Affimed NV - Net Profit Rate|Net Margin Allakos Inc.|igmbio.com (IGMS) - Company Sales Margin|Net Sales Margin ITOS|OCEA (Ocean Biomedical) - Net Profit Rate|Net Sales Margin TCBP (TC BioPharm (Holdings) PLC)|THRD - Return on Sales by Net Profit